Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127490 · ClinicalTrials.gov registry record · NA
Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia
A NA study, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01127490 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 25 participants.
The verdict
NCT01127490, a NA study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the characteristics of the nerves and the small veins in the skin of people with fibromyalgia. The investigators will then use this information to identify possible processes in the skin that may help explain why some people feel pain relief with the study drug (duloxetine) and others do not. Duloxetine affects certain chemicals in the brain called neurotransmitters. An abnormality in these chemicals is thought to be related to fibromyalgia. Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression. Duloxetine is approved for sale in the United States by the Food and Drug Administration (FDA) for the treatment of fibromyalgia.
Interventions
- DRUG Duloxetine
- PROCEDURE Skin biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-05-05 |
| Est. Completion | 2015-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127490
The ClinicalTrials.gov registry entry for NCT01127490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duloxetine is the first listed.
NCT01127490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127490 about?
NCT01127490 is a clinical study titled "Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia". The purpose of this study is to examine the characteristics of the nerves and the small veins in the skin of people with fibromyalgia. The investigators will then use this information to identify possible processes in the skin that may help explain why some people feel pain relief with the study dru...
What is the current status of trial NCT01127490?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2010-05-05. Estimated completion is 2015-09-09.
What interventions are being tested in trial NCT01127490?
The interventions under investigation include: Duloxetine (DRUG), Skin biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01127490?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.